Evidence map›Paper›PMID 30583592›Full record

ArticleNanomaterials (Basel, Switzerland)2018

On the Operational Aspects of Measuring Nanoparticle Sizes.

Jean-Marie Teulon, Christian Godon, Louis Chantalat, Christine Moriscot, Julien Cambedouzou, Michael Odorico, Johann Ravaux, Renaud Podor, Adèle Gerdil, Aurélie Habert and 3 more

Abstract read
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Jean-Marie TeulonUniv. Grenoble Alpes, CEA, CNRS, IBS, F-38000 Grenoble, France. jean-marie.teulon@cea.fr.
Christian GodonCEA, iBEB, LIRM, F-30207 Bagnols sur Cèze, France. christian.godon@cea.fr.
Louis ChantalatCEA, iBEB, LIRM, F-30207 Bagnols sur Cèze, France. louischantalat@hotmail.fr.
Christine MoriscotUniv. Grenoble Alpes, CNRS, CEA, IBS, F-38000 Grenoble, France. christine.moriscot@ibs.fr.
Julien CambedouzouInstitut de Chimie Séparative de Marcoule (ICSM), CEA, CNRS, ENSCM, Univ. Montpellier, F-30207 Marcoule, France. julien.cambedouzou@enscm.fr.ORCID 0000-0002-8811-5667
Michael OdoricoCEA, iBEB, LIRM, F-30207 Bagnols sur Cèze, France. michael.odorico@cea.fr.
Johann RavauxInstitut de Chimie Séparative de Marcoule (ICSM), CEA, CNRS, ENSCM, Univ. Montpellier, F-30207 Marcoule, France. johann.ravaux@cea.fr.
Renaud PodorInstitut de Chimie Séparative de Marcoule (ICSM), CEA, CNRS, ENSCM, Univ. Montpellier, F-30207 Marcoule, France. renaud.podor@cea.fr.ORCID 0000-0002-8103-1743
Adèle GerdilUMR3685 CEA-CNRS, NIMBE, LEDNA, CEA Saclay, F-91191 Gif sur Yvette, France. Adele.gm@outlook.fr.
Aurélie HabertUMR3685 CEA-CNRS, NIMBE, LEDNA, CEA Saclay, F-91191 Gif sur Yvette, France. aurelie.habert@cea.fr.
Nathalie Herlin-BoimeUMR3685 CEA-CNRS, NIMBE, LEDNA, CEA Saclay, F-91191 Gif sur Yvette, France. nathalie.herlin@cea.fr.
Shu-Wen W Chen478 rue Cyprien Jullin, F-38470 Vinay, France. cmft551@yahoo.com.
Jean-Luc PellequerUniv. Grenoble Alpes, CEA, CNRS, IBS, F-38000 Grenoble, France. jean-luc.pellequer@ibs.fr.ORCID 0000-0002-8944-2715

Funding

Commissariat à l'Énergie Atomique et aux Énergies Alternatives AFM-nanotoxEuropean Cooperation in Science and Technology TD-1002French Infrastructure for Integrated Structural Biology ANR-10 INSB-05-02Labex GRAL ANR-10-LABX-49-01
6 · The paper itself

Abstract

Nanoparticles are defined as elementary particles with a size between 1 and 100 nm for at least 50% (in number). They can be made from natural materials, or manufactured. Due to their small sizes, novel toxicological issues are raised and thus determining the accurate size of these nanoparticles is a major challenge. In this study, we performed an intercomparison experiment with the goal to measure sizes of several nanoparticles, in a first step, calibrated beads and monodispersed SiO₂ Ludox®, and, in a second step, nanoparticles (NPs) of toxicological interest, such as Silver NM-300 K and PVP-coated Ag NPs, Titanium dioxide A12, P25(Degussa), and E171(A), using commonly available laboratory techniques such as transmission electron microscopy, scanning electron microscopy, small-angle X-ray scattering, dynamic light scattering, wet scanning transmission electron microscopy (and its dry state, STEM) and atomic force microscopy. With monomodal distributed NPs (polystyrene beads and SiO₂ Ludox®), all tested techniques provide a global size value amplitude within 25% from each other, whereas on multimodal distributed NPs (Ag and TiO₂) the inter-technique variation in size values reaches 300%. Our results highlight several pitfalls of NP size measurements such as operational aspects, which are unexpected consequences in the choice of experimental protocols. It reinforces the idea that averaging the NP size from different biophysical techniques (and experimental protocols) is more robust than focusing on repetitions of a single technique. Besides, when characterizing a heterogeneous NP in size, a size distribution is more informative than a simple average value. This work emphasizes the need for nanotoxicologists (and regulatory agencies) to test a large panel of different techniques before making a choice for the most appropriate technique(s)/protocol(s) to characterize a peculiar NP.

Indexed as

AFMDLSmetrologynanoparticlesnanotoxicologySAXSSEMTEMwet-STEM

Identifiers

PMID30583592
PMCPMC6359205

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.